From the Journals
Preterm infant GER is a normal phenomenon
Traditional and pharmacologic interventions do not appear to work. Patience may be the best medicine.
Audio
Impact of varicella vaccination on herpes zoster is not what was expected
A prediction that herpes zoster incidence will rise.
Conference Coverage
Fundoplication works best for true PPI-refractory heartburn
Careful work-up rules out 79% of presumed PPI-refractory heartburn cases, but for the remaining 21% with true disease, fundoplication works best...
Conference Coverage
Hemostatic clipping cuts bleeds after large polyp removal
WASHINGTON – Using hemostatic clips to close mucosal defects following endoscopic removal of large colonic polyps cut the rate of severe, delayed...
From the Journals
Insurer denials of DAA therapy for HCV on the rise
About one in three patients had lack of fill approval by insurers.
Conference Coverage
Tenapanor shows safety, efficacy for irritable bowel syndrome
First-in-class tenapanor showed safety and efficacy, compared with placebo in a phase 3 trial of patients with constipation-predominant irritable...
News
CDC concerned about multidrug-resistant Shigella
if clinicians need to use antibiotics to treat patients who have Shigella infections, they should monitor these patients carefully.
Feature
HHS to allow insurers’ workaround on 2019 prices
The technique - called "silver loading" because it pushed price increases onto the silver-level plans in the ACA marketplaces - was used by many...
Conference Coverage
Shingles hospitalization occurs more often among IBD patients
Patients with inflammatory bowel disease who were hospitalized for a vaccine-preventable infection had twice the rate of shingles as did the...
From the Journals
Bezafibrate shows promise as second-line option for PBC
Approximately one-third of those who took bezafibrate had normal biomarkers after 24 months
Video
Web portal does not reduce phone encounters or office visits for IBD patients
WASHINGTON - The web portal MyChart allows patients to send messages to their providers, but does not improve patient outcomes.
From the Journals
Liver enzyme a marker of disease progression in primary biliary cholangitis
The liver enzyme autotaxin may be a useful noninvasive marker of disease progression in people with primary biliary cholangitis, new research has...
Video
VIDEO: Hepatitis C eradication cuts nonliver cancer rate
WASHINGTON - U.S. data from thousands of treated hepatitis C patients implicates the virus as carcinogenic and a factor in a wide range of...
News
FDA alerts clinicians to gastric balloon deaths
Four fatalities followed gastric perforation within a month of balloon placement.
Conference Coverage
Multiple therapies for NAFLD and NASH are now in phase 3 clinical trials
WASHINGTON – The trials are tricky, but these much-needed therapies may get conditional approval through reduction of liver inflammation and...
Practice Management Toolbox
New models of gastroenterology practice
Five new models of practice that have emerged in the past decade and have become viable choices for beginning and seasoned gastroenterologists...
Conference Coverage
NAFLD patients with abnormal liver tests may not get statins when indicated
WASHINGTON – Abnormal liver tests can make providers hesitant to start statins in NAFLD patients.
Conference Coverage
Percutaneous procedure gives alternative to anticoagulation for portal vein thrombosis
WASHINGTON – A transjugular intrahepatic portosystemic shunt is a feasible alternative to long-term anticoagulation for treating patients with...
Conference Coverage
Barrett’s segment length, low-grade dysplasia tied to increased risk of neoplastic progression
A Dutch study found that age at baseline endoscopy, length of Barrett’s segment, and low-grade dysplasia were significant predictors of neoplastic...
Video
App monitoring improves quality of IBD care
The HealthPROMISE phone app designed for remote monitoring of inflammatory bowel disease patients led to improved quality of care in a randomized...
Conference Coverage
Tumor analysis: Test all MSI-high patients for Lynch Syndrome
High microsatellite instability predicts LS across numerous tumor types, indicating a need for expanded LS testing in MSI-high patients.
Most Viewed
Commentary
Question 1 of 5
News From the AGA
-
Announcing the 2018 Section Research Mentor Award recipients -
Psychotherapy helps patients with chronic digestive disorders -
AGA Fellows application period now open -
AGA hosted productive Hill meeting advocating for GIs -
Federal spending agreement includes wins for medical community -
AGA leaders recognized for their contributions to the field -
Save the date for the 2019 Crohn’s & Colitis Congress -
AGA seeks regulatory relief for GIs -
Sessions at DDW® 2018 designed for trainees and early career GIs -
Better manage acute pancreatitis to improve patient outcomes
From the AGA Journals
-
-
Meta-analysis supports endoscopic surveillance of Barrett’s esophagus -
Study eyes liver transplantation after Region 5 UNOS downstaging -
-
AGA Clinical Practice Update: Screening for Barrett’s esophagus requires consideration for those most at risk -
-
Alpha fetoprotein boosted detection of early-stage liver cancer -
One in seven Americans had fecal incontinence -
Heavy drinking did not worsen clinical outcomes from drug-induced liver injury -
Model predicted Barrett’s esophagus progression
